No dietary control is required before or after treatment.
For the treatment and control of migrating and tissue larval stages of large strongyles, encysted mucosal 3rd and 4th stage small strongyle larvae and encysted inhibited 3rd stage small strongyle larvae in the mucosa administer 5ml of the product per 65 kg bodyweight daily for 5 days (= 7.5 mg fenbendazole/kg bodyweight daily for 5 days).
The product can be easily administered by mixing with grain or concentrate feed. The full daily dosage must be given as one administration.
Pregnant mares and foals may also be safely treated with fenbendazole at therapeutic dosage levels.
Assess bodyweight as accurately as possible before calculating the dosage. The use of a ‘weigh band’ is recommended.
Recommended dosing programme
Treatment of encysted inhibited and encysted mucosal dwelling larvae should be performed in the autumn (ideally late October/November) and again in the Spring (ideally in February).
However, for horses that fail to maintain condition or bought-in horses with unknown worming history, the treatment can be given at any time of the year.
Treatment with this product should form part of an integrated worming plan. Consult with your supplier for advice regarding wormers to use throughout the year.
Panacur has been extensively used for the treatment of worm infestations in exotic animal species. For further information on suggested dose rates, please contact the veterinary adviser of the Company.
Fenbendazole belongs to the benzimidazole (1‑BZ) class of anthelmintics.
Studies have indicated that inhibited 3rd stage small strongyle larvae represent 50% of the total larval population in the horse.